Skip to main content
Clinical Trials/CTRI/2022/05/042829
CTRI/2022/05/042829CompletedNot Applicable

Comparison of erector spinae plane block and local anaesthetic infiltration of the incision site with 0.375% ropivacaine for postoperative analgesia in percutaneous nephrolithotomy.

velammal medical college1 site in 1 country100 target enrollmentStarted: January 6, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
100
Locations
1
Primary Endpoint
Postoperative Numeric rating pain scale

Study Overview

Brief Summary

Erector spinae block is found to be effective in variety of procedures.This study is designed to evaluate the efficacy of USG guided Erector spinae block(ESP) for postoperative analgesia following percutaneous nephrolithotomy(pcnl).It is a prospective double blind parallel group study comparing erecor spinae block with local site infiltration with 0.375% ropivacaine for postoperative pain relief for pcnl.Inclusion criteria included ASA 1 and 2 patients aged between 18 and 70 years  of both sexes.Exclusion criteria included BMI>35 KG/m2 ,ASA 3 AND 4,allergic history to local anaesthetics,sepsis or bacreimia.Patients in group L received 20ml of 0.375% ropivacaine at the incision site subcutaneously with hupodermic needle locally and Group E received USG guided ESP block with 0.375% ropivacaine at T10 level.Numeric rating pain scale was measured postoperatively at 30 min,60 min then hourly for 6 hours followed by 4th hourly for 24 hours.The primary objective of the study was to compare NRS scores postoperatively between two groups.The secondary objective was to compare the rescue analgesia requirement between both gropus for 24 hours.

Study Design

Study Type
Interventional
Allocation
Computer generated randomization
Masking
Participant and Investigator Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 70.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •Inclusion criteria.
  • •Patients undergoing PCNL under general anaesthesia (GA) of both genders belonging to ASA I and II, between 18 to 70 years of age, were included.

Exclusion Criteria

  • •Exclusion criteria – ASA – III , IV contraindications to peripheral nerve blocks, body mass index >35 kg/m2, sepsis or bacteraemia, and cognitive disability.

Outcomes

Primary Outcomes

Postoperative Numeric rating pain scale

Time Frame: Postoperative Numeric rating scale 0 to 10 measured over 24 hours post procedure

Secondary Outcomes

  • Postoperative analgesic requirement(time for first rescue analgesia and total analgesic dose required postoperatively)

Investigators

Sponsor
velammal medical college
Sponsor Class
Research institution and hospital

Study Sites (1)

Loading locations...

Similar Trials